title: Side effects of treatment with I-131-meta-iodobenzylguanidine (I-131-MIBG) in neuroblastoma patients.
authors.affiliation: Werkgroep Kindertumoren, Emma Kinderziekenhuis, Amsterdam, The Netherlands.
authors.forename: P A
authors.initials: PA
authors.lastname: Voûte
authors.forename: C A
authors.initials: CA
authors.lastname: Hoefnagel
authors.forename: J
authors.initials: J
authors.lastname: de Kraker
authors.forename: M
authors.initials: M
authors.lastname: Majoor
mesh_terms: D019797:3-Iodobenzylguanidine; D000328:Adult; D001853:Bone Marrow / Q000473:pathology; D001859:Bone Neoplasms / Q000556:secondary; D002648:Child; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007462:Iodobenzenes / Q000009:adverse effects* / Q000627:therapeutic use / Q000633:toxicity; D008297:Male; D009447:Neuroblastoma / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
chemical_list: D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine